5LZ-18942-21082
1 vaccination
1 coded response
2 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 171 / PA
- Registered
- 2021-07-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Janssen/Johnson & Johnson
-
2021-07-26
Registered in v-safe
- 2021-09-30
-
2022-04-01
Survey response — 12 months, dose 1MedDRA: Migraine with aura — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Migraine with auraMedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Report sent to call center — 12 months, dose 1Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-06
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Janssen/Johnson & Johnson | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-01 | Successful 2022-04-06 |
Does not wish to fill out VAERS report |
Free text
Release 11 — 12 months, dose 1
Symptoms: Migraine with aura
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Migraine with aura | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release